Novel therapeutics acting via purine receptors
- 1 May 1991
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (10), 1399-1410
- https://doi.org/10.1016/0006-2952(91)90555-j
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Selective A1-Antagonists for Treatment of Cognitive DeficitsNucleosides and Nucleotides, 1991
- C2,N6-Disubstituted adenosines: synthesis and structure-activity relationshipsJournal of Medicinal Chemistry, 1989
- N6-Bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptorJournal of Medicinal Chemistry, 1989
- N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptorJournal of Medicinal Chemistry, 1988
- Functional Renal Insufficiency: Role of AdenosineNeonatology, 1988
- N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activityJournal of Medicinal Chemistry, 1987
- N6-Substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptorsJournal of Medicinal Chemistry, 1986
- Cardiovascular effects of adenosine in man; possible clinical implicationsProgress in Neurobiology, 1986
- Is there a basis for distinguishing two types of P2-purinoceptor?General Pharmacology: The Vascular System, 1985
- THE EFFECT OF THEOPHYLLINE ETHYLENE DIAMINE ON RENAL FUNCTION IN CONTROL SUBJECTS AND IN PATIENTS WITH CONGESTIVE HEART FAILURE 1JCI Insight, 1949